Study library
LongLifeScan should not be based on hype, but on traceable sources. This study library collects important work on biomarkers, supplements and health areas.
Studies do not replace medical advice. They help interpret claims and make evidence limits visible.
This review explains why ApoB is relevant for atherosclerotic risk and why LDL-C alone may not always capture particle-related risk fully.
The ADA Standards of Care describe diabetes diagnosis, classification and management. HbA1c is a central marker for interpreting glucose metabolism.
This review discusses inflammation in atherosclerotic disease and hs-CRP as a marker of residual inflammatory risk signals.
This meta-analysis evaluates omega-3 fatty acids in relation to cardiovascular outcomes. The evidence is context-dependent and should not be treated as a generic recommendation.
This position stand describes creatine monohydrate as a well-studied supplement in sport and training contexts and discusses efficacy and safety with appropriate use.
This analysis reports overall lower systolic and diastolic blood pressure with magnesium supplementation, while emphasizing context, dose and study differences.
Understood the study?
Studies are valuable, but not automatically personally relevant. LongLifeScan turns knowledge into priorities and next steps.